{"organizations": [], "uuid": "23e6732935e7db7ededefa09c3c56a8144215389", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180222.html", "section_title": "Archive News &amp; Video for Thursday, 22 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-daiichi-sankyo-initiates-phase-1-s/brief-daiichi-sankyo-initiates-phase-1-study-of-ds-1062-in-patients-with-advanced-non-small-cell-lung-cancer-idUSFWN1QC0V4", "country": "US", "domain_rank": 408, "title": "BRIEF-Daiichi Sankyo Initiates Phase 1 Study Of DS-1062 In Patients With Advanced Non-Small Cell Lung Cancer", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.726, "site_type": "news", "published": "2018-02-22T21:13:00.000+02:00", "replies_count": 0, "uuid": "23e6732935e7db7ededefa09c3c56a8144215389"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-daiichi-sankyo-initiates-phase-1-s/brief-daiichi-sankyo-initiates-phase-1-study-of-ds-1062-in-patients-with-advanced-non-small-cell-lung-cancer-idUSFWN1QC0V4", "ord_in_thread": 0, "title": "BRIEF-Daiichi Sankyo Initiates Phase 1 Study Of DS-1062 In Patients With Advanced Non-Small Cell Lung Cancer", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "sankyo", "sentiment": "negative"}, {"name": "daiichi", "sentiment": "negative"}, {"name": "daiichi sankyo co ltd", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 22 (Reuters) - Daiichi Sankyo Co Ltd:\n* DAIICHI SANKYO INITIATES PHASE 1 STUDY OF DS-1062 IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-22T21:13:00.000+02:00", "crawled": "2018-02-23T16:13:58.003+02:00", "highlightTitle": ""}